<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Pediatric Gastroesophageal Reflux Disease: Developing Drugs for Treatment; Draft Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Pediatric Gastroesophageal Reflux Disease: Developing Drugs for Treatment; Draft Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2017-10-27 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Pediatric Gastroesophageal Reflux Disease: Developing Drugs for Treatment." The purpose of this draft guidance is to assist sponsors in the clinical development of drugs for the treatment of gastroesophageal reflux disease (GERD) in the pediatric patient population, including guidance on clinical presentation by age and disease, study populations, endpoints, and pharmacometr...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2017-23436</p>
    <p><strong>Publication Date:</strong> 2017-10-27</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2017/10/27/2017-23436/pediatric-gastroesophageal-reflux-disease-developing-drugs-for-treatment-draft-guidance-for-industry">https://www.federalregister.gov/documents/2017/10/27/2017-23436/pediatric-gastroesophageal-reflux-disease-developing-drugs-for-treatment-draft-guidance-for-industry</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2017-23436</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
